<b>Background/Objectives</b>: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease for which serum vascular endothelial growth factor D (VEGF-D) is a recommended diagnostic biomarker. Here, VEGFD is linked to cystic disease of lung.